Contrast-agent phase effects: An experimental system for analysis of susceptibility, concentration, and bolus input function kinetics

Magnetic Resonance in Medicine

Volumn 38, Issue 6, 1997, Pages 990-1002

  Akbudak, Erbil ^a,b   Norberg, Richard E ^b   Conturo, Thomas E ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Contrast agents; MRI; Perfusion; Susceptibility

Indexed keywords

MAGNETIC MOMENTS; MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY;

ACCURATE MEASUREMENT; ARTERIAL INPUT FUNCTION; CONTRAST AGENT; CONTROLLED CONDITIONS; CYLINDRICAL PHANTOMS; EFFECTIVE MAGNETIC MOMENTS; ORIENTATION DEPENDENCE; PERFUSION;

MOLAR CONCENTRATION;

GADODIAMIDE; GADOVERSETAMIDE; UNCLASSIFIED DRUG;

ARTICLE; BOLUS INJECTION; DRUG DIFFUSION; MATHEMATICAL MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PHARMACOKINETICS;

EID: 0030701922     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910380619     Document Type: Article

References (29)

1. R. M. Weisskoff, S. Kiihne, MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood. Magn. Reson. Med. 24, 375-383 (1992).
2. E. Akbudak, T. E. Conturo, Arterial input functions from MR phase imaging. Magn. Reson. Med. 36, 809-815 (1996).
3. T. E. Conturo, P. B. Barker, V. P. Mathews, L. H. Monsein, R. N. Bryan, MR imaging of cerebral perfusion by phase-angle reconstruction of bolus paramagnetic-induced frequency shifts. Magn. Reson. Med. 27, 375-390 (1992).
4. 1H water spectroscopy. J. Magn. Reson. Imaging 3(P), 62 (1993).
5. A. J. deCrespigny, T. P. L. Roberts, J. Kucharcyzk, M. E. Moseley, Improved sensitivity to magnetic susceptibility contrast. Magn. Reson. Med. 30, 135-137 (1993).
6. T. E. Conturo, J. D. Strandberg, B. J. Soher, P. B. Barker, J. H. Anderson, Assessment of tumor perfusion and blood brain barrier leakage with phase enhancement effects of contrast agents. Radiology 189(P), 184 (1993).
7. B. R. Rosen, J. Belliveau, J. M. Vevea, T. J. Brady, Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14, 249-265 (1990).
8. K. B. Larson, W. H. Perman, J. S. Perlmutter, M. H. Gado, J. M. Ollinger, K. Zierler, Tracer-kinetic analysis for measuring regional cerebral blood flow by dynamic nuclear magnetic resonance imaging. J. Theoret. Biol. 170, 1-14 (1994).
9. T. E. Conturo, G. D. Smith, Signal-to-noise in phase angle reconstruction: dynamic range extension using phase reference offsets. Magn. Reson. Med. 15, 420-437 (1990).
10. W. C. Dickinson, The time average magnetic field at the nucleus in nuclear magnetic resonance experiments. Phys. Rev. 81, 717-732 (1951).
11. J. R. Zimmerman, M. R. Foster, Standardization of NMR high resolution spectra. J. Phys. C: Solid State Phys. 61, 282-289 (1957).
12. S. C. Chu, Y. Xu, J. A. Balschi, C. S. Springer, Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn. Reson. Med. 13, 239-62 (1990).
13. E. Akbudak, T. E. Conturo, Theory of phase enhancement contrast agent mechanisms: microscopic effects, in "Proc., SMR, 2nd Annual Meeting, San Francisco, 1994," p. 938.
14. E. Akbudak, T. E. Conturo, A phantom system for accurate and precise quantitation of contrast agent susceptibility and single vessel bolus flow dynamics, in "Proc. SMR, 3rd Annual Meeting, Nice, France, 1995," p. 867.
15. J. A. Pople, W. G. Schneider, H. J. Bernstein, "High-Resolution Nuclear Magnetic Resonance," pp. 20, 82, McGraw-Hill, New York, 1959.
16. D. Craik, "Magnetism: Principles and Applications." John Wiley and Sons, Chinchester, 1995.
17. C. A. Reilly, H. M. McConnell, R. G. Meisenheimer, Nuclear magnetic resonance spectra of annular samples. Phys. Rev. 98, 264-265 (1955).
18. A. A. Bothner-By, R. E. Glick, Specific medium effects in nuclear magnetic resonance spectra of liquids. J. Am. Chem Soc. 78, 1071-1072 (1956).
19. P. Langevin, Magnétisme et théorie des électrons. Ann. Chim. Phys. 5, 70-127 (1905).
20. J. H. VanVleck, "Electric and Magnetic Susceptibilities," Oxford University Press, London, 1932.
21. L. N. Mulay, "Magnetic Susceptibility," p. 1776, Interscience, New York, 1963.
22. A. Haase, J. Frahm, D. Matthaei, W. Hanicke, K.-D, Merboldt, FLASH imaging: rapid NMR imaging using low flip-angle pulses. J. Magn. Reson. 67, 258-266 (1986).
23. D. R. Lide, "CRC Handbook of Chemistry and Physics," 75th ed, pp. 4-118, CRC Press, Boca Raton, 1994-1995.
24. 0 inhomogeneity, Magn. Reson. Med. 35, 126-130 (1996).
25. W. H. Perman, M. H. Gado, K. B. Larson, J. S. Perlmutter, Simultaneous MR acquisition of arterial and brain signal-time curves. Magn. Reson. Med. 28, 74-83 (1992).
26. U. P. Schmiedl, J. Kenney, K. R. Maravilla, Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR. Amer. J. Neuroradiol. 13, 5-14 (1992).
27. N. Wilke, C. Simm, J. Zhang, J. Ellermann, X. Ya, H. Merkle, G. Path, H. Ludemann, R. J. Bache, K. Ugurbil, Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn. Reson. Med. 29, 485-497 (1993).
28. M. F. Wendland, M. Saeed, K. K. Yu, T. P. L. Roberts, K. Lauerma, N. Derugin, J. Varadarajan, A. D. Watson, C. B. Higgins, Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn. Reson. Med. 32, 319-329 (1994).
29. L. Ostergaard, A. G. Sorensen, K. K. Kwong, R. M. Weisskoff, C. Gyldensted, B. R. Rosen, High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn. Reson. Med. 36, 726-736 (1996).